BioSpace News Archive

Drug Development

Moderna Makes Headway with COVID-19 Booster, Flu Vaccine

Moderna announced its Omicron-containing COVID-19 booster candidate, mRNA-1273.214, demonstrated superior antibody response against Omicron in its Phase II/III study.

June 8, 2022
·
3 min read
·
Mark Terry
Policy

FTC Probes Prescription Drug Middlemen as Drug Prices Soar

Calls for a reform of drug prices have become a regular occurrence, particularly in the midst of political campaigns. Yet a new report shows the median price of a new drug launched in 2021 was $180,000.

June 8, 2022
·
3 min read
·
Alex Keown
Drug Development

Vertex Kidney Disease Drug Scores FDA Breakthrough Therapy Designation

The FDA granted Breakthrough Therapy Designation to Verttex’s candidate inaxaplin (VX-147). for the treatment of APOL1-mediated focal segment glomerulosclerosis.

June 8, 2022
·
2 min read
·
Hayley Shasteen
Drug Development

Sanofi Celebrates Latest Dupixent Approval, Cambridge Crossing Opening

The approval expands the rapidly growing number of indications for Dupixent, which is the first and only biologic medication with the FDA’s nod to treat atopic dermatitis from infancy to adulthood.

June 8, 2022
·
2 min read
·
Vanessa Doctor, RN
Career Advice

Sales and Marketing Jobs in the Life Sciences Industry: a Comprehensive Guide

Sales and marketing roles in the life sciences field are in high demand. To help with your job search, we’ve compiled a guide to sales and marketing jobs in the life sciences industry.

June 8, 2022
·
2 min read
·
Franklin Carpenter
Policy

Order in the Court: Novo Nordisk, Eli Lilly & BMS Face Legal Battles

Novo Nordisk and Eli Lilly came under legal scrutiny this week, while BMS forked over $11 million to settle claims over anticompetitive tactics.

June 8, 2022
·
3 min read
·
Alex Keown
Business

Actor Greg Grunberg Discusses New Series: “The Care Giver”

Greg Grunberg, who has appeared in multiple Star Wars projects, has partnered with Jazz Pharmaceuticals to bring “The Care Giver”, a video web series, to life.

June 8, 2022
·
4 min read
·
Alex Keown
Drug Development

Mineralys Therapeutics Rakes in $118M for Hypertension Therapy

Mineralys Therapeutics, a clinical-stage biopharmaceutical company focused on developing a best-in-class, novel therapy for high blood pressure, closed a $118 million Series B investment round.

June 8, 2022
·
2 min read
·
Paolo Besabella
Drug Development

Global Roundup: Denmark’s Ascendis Sees “Real Control” in Hypothyroidism

At ENDO 2022, Ascendis will share Phase II and III data showing clinical efficacy for its investigational product candidate for hypoparathyroidism. For this and more, see inside.

June 8, 2022
·
7 min read
·
Alex Keown
Money on the Move: Tech Innovation Reigns Supreme

Funding this week went mostly to companies with sophisticated tech platforms. Financing rounds will support platforms for tumor-targeting antibodies, genome-scale nucleic and acid imaging.

June 8, 2022
·
4 min read
·
Hannah Chudleigh